Gilead Sciences late Tuesday blew past Q1 revenue and earnings forecasts as sales of its new hepatitis C drug Sovaldi far exceeded expectations, but fellow big biotech Amgen missed expectations. Gilead (GILD) stock was up 2.5% after hours, after its Q1 report included sales of $2.27 billion for the expensive Sovaldi, which it started selling in December. Analyst sales estimates ranged from near $1 billion to $2 billion. “We believe expectations
In just 16 years, Netflix has twice revolutionized the home entertainment industry, first with a subscription-based unlimited DVD rental program and more recently with its game-changing online streaming video service. But its success was never a certainty, especially in its scrappy early days when it charged for each movie rented. Today Netflix (NFLX) has more than 48 million subscribers for its Internet video service, which offers a collection of
Amazon.com, which plans this year to expand its AmazonFresh online grocery business from West Coast test areas to 20 urban centers across the U.S. and possibly overseas, might soon offer the service in parts of the greater Chicago and New York metropolitan areas, and Washington, D.C. Bill Bishop, a supermarket analyst and chief architect of retail technology consulting firm Brick Meets Click, says his “best educated guess” is that Amazon (AMZN)